Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Elderly SLE patients show fewer typical symptoms and more hormonal side effects.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Various medications and vaccines can cause serious side effects.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Lichen planopilaris may have a genetic link.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

A rare skin condition caused scarring hair loss on the scalp.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Managing severe infections in SLE patients requires tailored treatment strategies.

PAS III can cause multiple autoimmune diseases with noticeable skin issues.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

Mutations in the LSS gene cause hair loss and may affect brain development, with varying severity.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Treatment improved some symptoms but not all.

Patients with lichen planus should be tested for hepatitis C.

Lithium can cause skin discoloration even at normal levels, so monitor for signs of intoxication.

The new criteria for classifying lupus are more accurate and comprehensive.

A rare case of lupus linked to thymoma shows complex diagnosis and management challenges.

Discoid lupus erythematosus can be mistaken for a skin infection, complicating diagnosis and treatment.

Lichen planus is not linked to metabolic syndrome, but it is associated with higher rates of high blood pressure, high triglycerides, and low HDL cholesterol.

Mitochondrial dysfunction and oxidative stress may play a role in Lichen Planopilaris.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

The updated criteria improve the accuracy of diagnosing lupus.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.